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The light-organ symbiont Vibrio fischeri releases N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramylalanyl-
-glutamyldiaminopimelylalanine, a disaccharide-tetrapeptide component of peptidoglycan that is referred to
here as “PG monomer.” In contrast, most gram-negative bacteria recycle PG monomer efficiently, and it does
not accumulate extracellularly. PG monomer can stimulate normal light-organ morphogenesis in the host
squid Euprymna scolopes, resulting in regression of ciliated appendages similar to that triggered by infection
with V. fischeri. We examined whether the net release of PG monomers by V. fischeri resulted from lytic
transglycosylase activity or from defects in AmpG, the permease through which PG monomers enter the
cytoplasm for recycling. An ampG mutant displayed a 100-fold increase in net PG monomer release, indicating
that AmpG is functional. The ampG mutation also conferred the uncharacteristic ability to induce light-organ
morphogenesis even when placed in a nonmotile flaJ mutant that cannot infect the light-organ crypts. We
targeted five potential lytic transglycosylase genes singly and in specific combinations to assess their role in PG
monomer release. Combinations of mutations in ltgA, ltgD, and ltgY decreased net PG monomer release, and
a triple mutant lacking all three of these genes had little to no accumulation of PG monomers in culture
supernatants. This mutant colonized the host as well as the wild type did; however, the mutant-infected squid
were more prone to later superinfection by a second V. fischeri strain. We propose that the lack of PG monomer
release by this mutant results in less regression of the infection-promoting ciliated appendages, leading to this
propensity for superinfection.
Microbe-associated molecular patterns (MAMPs) are rec-
ognized by hosts in a variety of pathogenic and symbiotic re-
lationships. MAMP is an umbrella term for a variety of semi-
conserved bacterial molecules, including lipopolysaccharide,
lipoproteins, flagella, and peptidoglycan (PG), that are sensed
by conserved host surveillance mechanisms (e.g., the innate
immune system), triggering context-dependent reactions to
bacterial colonization. Mounting evidence shows that PG-de-
rived MAMPs play important and previously underappreciated
roles in host-bacterium interactions (11).
The PG layer of gram-negative bacteria is a rigid network in
the periplasm that protects against osmotic lysis and helps to
determine cell size and shape while still allowing diffusion of
molecules into the cell (14). In PG, repeated subunits of N-
acetylglucosamine and N-acetylmuramic acid are connected to
a short pentapeptide side chain of L-alanyl-D--glutamyl-meso-
diaminopimelyl-D-alanyl-D-alanine (Ala-Glu-DAP-Ala-Ala). Ad-
jacent peptides are cross-linked through Ala-DAP or DAP-DAP
peptide bonds, and side chains are converted to tetra-, tri-, and
dipeptides through the action of carboxypeptidases in the
periplasm (19, 49).
Despite its mechanical stability, PG is a dynamic structure
that undergoes remodeling and recycling. Murein hydrolases,
including lytic transglycosylases, hydrolyze PG to allow the
insertion of new material as the cell grows or to accommodate
structures that span the periplasm (61, 72). Lytic transgly-
cosylases cleave the N-acetylmuramic acid--1,4-N-acetyl-
glucosamine linkage in PG and catalyze the formation of a
1,6-anhydro bond on the N-acetylmuramic acid (28). After
cleavage, PG monomers enter the cytoplasm through the
permease AmpG (30) and are recycled and ultimately rein-
corporated into PG (20). Murein hydrolase activity and the
recycling of PG monomers presumably allow for growth and
cell expansion; however, Escherichia coli mutants lacking
ampG or several lytic transglycosylases were not affected in
growth or cell division (25, 33).
Presumably because PG monomers are usually efficiently
recycled, only a few bacteria are known to release PG mono-
mers during growth. These include Neisseria gonorrhoeae (62)
and Bordetella pertussis (57), which cause gonorrhea and
whooping cough, respectively. These pathogens each release
N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramylalanyl--
glutamyldiaminopimelylalanine (referred to herein as “PG
monomer”), which triggers the death of ciliated host cells (12,
38, 42), but the basis for their shedding of PG monomers
differs. B. pertussis release of PG monomer, or “tracheal cyto-
toxin” (TCT), apparently is due to disruption of ampG expres-
sion by the insertion of an IS481 element 90 bp upstream of
this gene (36), and artificially expressing ampG in B. pertussis
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decreased PG monomer release (36, 43). However, in N. gon-
orrhoeae the activities of the lytic transglycosylases LtgA (9)
and LtgD (10) appear to be responsible for the release of PG
monomer or “PG cytotoxin” (PGCT). An ampG mutant in N.
gonorrhoeae showed a sevenfold increase in PG monomer re-
lease, suggesting a functional AmpG and PG recycling pathway
(18). Unfortunately, humans are the host for N. gonorrhoeae
and B. pertussis, hindering examination of the effects of PG
monomer during natural infections.
Recently, the bioluminescent marine bacterium Vibrio fisch-
eri was found to release the same PG monomer as that released
by N. gonorrhoeae and B. pertussis (31). V. fischeri is a light-
organ symbiont of the Hawaiian bobtail squid, Euprymna sco-
lopes, and this host-bacterium association can be reconstituted
in the laboratory. E. scolopes hatchlings contain ciliated ap-
pendages that increase water flow across the light organ and
help facilitate infection (40, 41, 48). During initial colonization,
V. fischeri triggers regression of these ciliated fields (15, 47),
and this can be mimicked by adding PG monomers to the
seawater (31). In this study, we constructed and analyzed mu-
tants to determine the contributions of lytic transglycosylases
and AmpG to PG monomer release in V. fischeri. We also
determined the abilities of the mutants to colonize and stim-
ulate morphogenesis of the squid host.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains used in this
study are listed in Table 1. E. coli was incubated at 37°C in LB medium (44),
brain heart infusion medium (Difco, Sparks, MD), or, for PG monomer analysis,
M9 minimal medium (60) with 30 mM glucose. When added to LB medium (44)
for selection of E. coli, chloramphenicol (Cm) and kanamycin were used at
concentrations of 20 and 40 g ml1, respectively. For selection of E. coli with
erythromycin (Em), 150 g ml1 was added to brain heart infusion medium. V.
fischeri was grown at 28°C in LBS (63) or at 24°C in SWT and SWTO (5) or
minimal salts medium (0.340 mM NaPO4 [pH 7.5], 0.05 M Tris [pH 7.5], 0.3 M
NaCl, 0.05 M MgSO4 · 7H2O, 0.01 M CaCl2 · 2H2O, 0.01 M NH4Cl, 0.01 M KCl,
0.01 mM FeSO4 · 7H2O, and 30 mM glucose). When added to LBS for selection
of V. fischeri, Cm, kanamycin, and Em were used at concentrations of 2, 100, and
5 g ml1, respectively. Agar was added to a final concentration of 1.5% for solid
media.
DNA and plasmid manipulations. Standard methods were used to manipulate
plasmids and DNA fragments. Plasmids were transformed and maintained in E.
coli DH5, except plasmids with the R6K origin of replication or pCR-BluntII
TOPO, which were maintained in DH5pir and TOP10, respectively. Restric-
tion enzymes and T4 DNA ligase were obtained from New England Biolabs
(Ipswich, MA). Chromosomal DNA was purified using the Easy-DNA kit (In-
vitrogen, Carlsbad, CA). Plasmids were isolated using the QIAprep Spin Mini-
prep kit (Qiagen, Valencia, CA) or the GenElute Plasmid Miniprep kit (Sigma,
St. Louis, MO). The Zero Blunt TOPO PCR cloning kit (Invitrogen, Carlsbad,
CA) was used to clone PCR products into pCR-BluntII TOPO. DNA fragments
were purified using the DNA Clean & Concentrator-5 kit (Zymo Research,
Orange, CA). PCR was performed using KOD HiFi DNA polymerase (Novagen,
Madison, WI) by following the manufacturer’s recommendations for cycle pro-
grams based on predicted product size. The annealing temperature for each
primer was usually determined by subtracting 5°C from the lower calculated
primer melting temperature. PCR was performed using an iCycler (Bio-Rad
Laboratories, Hercules, CA). DNA sequencing was conducted on an ABI auto-
mated DNA sequencer at the University of Michigan DNA Sequencing Core,
and sequences were analyzed using Sequencher 4.6 (Gene Codes, Ann Arbor,
MI). Oligonucleotides (Table 1) were obtained from Integrated DNA Technol-
ogies (Coralville, IA).
Mutant construction. Descriptions of select plasmids and the primers used in
their construction are provided in Table 1. Construction of mutant strains and
alleles is outlined in Table 1, and a summary follows. To generate plasmid
insertion mutants, an internal fragment of each targeted gene was PCR amplified
and either cloned directly into pEVS122 (a vector that does not replicate in V.
fischeri) or cloned into pCR-BluntII TOPO and subsequently subcloned into
pEVS122. The resulting plasmids were mobilized into V. fischeri, and plating on
LBS-Em selected for transconjugants that had undergone homologous recom-
bination between the genome and the internal gene fragment, enabling us to
isolate vector integration mutants. In this way, plasmids pDMA48, pDMA89,
pDMA90, pDMA91, pDMA108, and pDMA109 were used to generate muta-
tions in ampG, ltgA, ltgY, ltgD, lysM, and ltgE, respectively. In-frame ampG,
ltgA, and ltgD deletion alleles were constructed in plasmids pDMA110,
pDMA187, and pDMA199, respectively, such that the region between the start
and stop codon of each target gene was replaced by a 6-bp restriction enzyme
recognition site. These in-frame deletion mutations were placed in ES114 or in
mutant backgrounds by allelic exchange. All mutants were confirmed by PCR.
Constructs were generated in E. coli and transferred to V. fischeri by triparental
mating using E. coli CC118pir pEVS104 as a conjugative helper plasmid (65).
Bioinformatic analyses. Protein sequence comparisons to GenBank entries
were generated using BLAST-P (2) and the BLOSUM62 scoring matrix (26).
Genomes with similar regions surrounding the lytic transglycosylase open read-
ing frames (ORFs) were found using the SEED pinned region search (54). To
assess genetic context within the Vibrionaceae family, we compared local gene
arrangement in V. fischeri ES114 (59) to that in the genomes of Vibrio algino-
lyticus 12G01, Vibrio angustum S14, Vibrio campbellii AND4, Vibrio cholerae O1
biovar eltor strain N16961 (23), Vibrio harveyi ATCC BAA-1116, Vibrio para-
haemolyticus RIMD 2210633 (37), Vibrio vulnificus CMCP6 (8), and Photobac-
terium profundum SS9 (69). Sequence alignments were performed with MEGA
4.0 using the default settings (66). The similarity and identity between homologs
reported were determined with MatGAT using the default settings (7).
PG monomer detection and quantification. Culture supernatants were subject
to solid-phase extraction and reversed-phase high-pressure liquid chromatogra-
phy (HPLC) as described previously (12, 31). Briefly, cultures were grown in
minimal medium supplemented with 30 mM glucose at 24°C until reaching an
optical density at 595 nm (OD595) of 	0.8 to 1.0 (mid- to late-log growth).
Cultures were centrifuged either in 15-ml Falcon tubes (two spins at 4,500
 g for
10 min each at 4°C) or by sequential spins in a 250-ml centrifuge bottle at 4,500 

g and then in a 30-ml centrifuge bottle at 8,500 
 g, each for 10 min at 4°C, to
pellet cells. Culture supernatants were adjusted to 1% trifluoracetic acid (TFA)
with 100% TFA and filtered through an 0.22-m mixed cellulose membrane
filter unit (Fisher Scientific, Hanover Park, IL). Each sample was desalted using
a C18 Plus Sep-Pak cartridge (Waters Corporation, Milford, MA), and each
cartridge was prepared prior to receiving the sample with 100% methanol and
two washes with 0.1% TFA in water. Samples were then loaded and allowed to
flow by gravity through the column. After complete loading, the column was
washed twice with 10 ml of 0.1% TFA in water. Materials retained in the column
were eluted with 4 ml of 100% methanol and concentrated to dryness under a
vacuum with a SpeedVac Plus (ThermoSavant, Holbrook, NY). Two hundred
microliters of drying reagent (2 parts H2O to 2 parts methanol to 1 part trieth-
ylamine acetate [TEA]) was added to the dried C18 fraction, vortexed, and dried
under vacuum in a SpeedVac Plus. Thirty microliters of phenylisothiocyanate
(Pierce, Rockford, IL) reagent (10% H2O, 75% methanol, 10% TEA, and 5%
phenylisothiocyanate) was added to derivatize each sample, and the resulting
phenylthiocarbamyl (PTC) derivatives were then dried.
Reversed-phase HPLC was employed to separate the PTC-PG monomers
from the extract. Buffer A consisted of 150 mM sodium acetate and 0.05% TEA
brought to pH 6.35 with glacial acetic acid, and buffer B consisted of a 60:40 mix
of acetonitrile and water. Samples were resuspended in a 92:8 solution of buffer
A and buffer B such that it was 100-fold more concentrated than culture super-
natant. Each sample was vortexed, and 200 l was injected into the HPLC. A
Brownlee Spheri-5, RP-8 C8 4.6- 
 220-mm column with a 4.6- 
 30-mm guard
column of the same matrix was used for all chromatographic separations (Perkin-
Elmer, Waltham, MA). Column temperature was maintained at 35°C with a flow
rate of 1 ml/min. The gradient (ratio of buffer A to buffer B) was as follows: 0
min, 92:8; 13 min, 65:35; 15 min, 0:100; 35 min, 0:100; and 36 min, 92:8, with
reinjection at 45 min. Absorption at 254 nm was detected using a Spectraflow 757
variable- UV detector. Peak areas and retention times were recorded using
Dynamic MacIntegration software, version 1.4.1 or 1.4.3. PTC-PG monomer
retention time was approximately 13.2 min. A PG monomer standard (B. per-
tussis TCT) was also phenylisothiocyanate derivatized and run to compute pico-
moles of PG monomer in each sample based on comparisons of peak areas. For
experiments assessing PG monomer released by mutant strains, PG monomer
releases from wild-type V. fischeri ES114 and E. coli MG1655 were run as
controls. Over 14 different experiments, V. fischeri ES114 samples averaged
21.2  3.9 (standard error) nM PG monomer per OD595. As a negative control,
E. coli MG1655 was included in six experiments and averaged 2.9 1.6 (standard
error) nM PG monomer per OD595, with PG monomer being below the limit of
detection (	1.5 nM per OD595) in three of these experiments.
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CC118pir (ara-leu) araD lac74 galE galK phoA20 thi-1 rpsE rpsB argE(Am) recA pir 27
DH5 F 80dlacZ(lacZYA-argF)U169 deoR supE44 hsdR17 recA1 endA1 gyrA96 thi-1 relA1 22
DH5pir DH5 lysogenized with pir 16
MG1655 F  ilvG rfb50 rph1 C. Gross




AKD200 ES114 mini-Tn7 insertion; Cmr A. Dunn
DM131 ES114 flaJ::aph; Knr D. Millikan
DMA350 ES114 ampG::pDMA48; Emr This study
DMA352 ES114 ampG (allele exchanged from pDMA110 into ES114) This study
DMA354 DM131 ampG (allele exchanged from pDMA110 into ES114); Knr This study
DMA360 ES114 ltgA::pDMA89; Emr This study
DMA361 ES114 ltgY::pDMA90; Emr This study
DMA362 ES114 ltgD::pDMA91; Emr This study
DMA363 ES114 ltgA (allele exchanged from pDMA187 into ES114) This study
DMA368 ES114 ltgD (allele exchanged from pDMA199 into ES114) This study
DMA369 ES114 ltgA ltgD (allele exchanged from pDMA199 into DMA363) This study
DMA380 ES114 ltgE::pDMA109; Emr This study
DMA385 ES114 lysM::pDMA108; Emr This study
DMA386 ES114 ltgA ltgY::pDMA90; Emr This study
DMA387 ES114 ltgD ltgY::pDMA90; Emr This study
DMA388 ES114 ltgA ltgD ltgY::pDMA90; Emr This study
ES114 Wild-type isolate from E. scolopes 3
Plasmids
pCR-BluntII TOPO TOPO PCR cloning vector; Knr Invitrogen
pDMA46 Internal ampG fragment (PCR product; primers dma30 and dma31, ES114 template) in pCR-BluntII TOPO; Knr This study
pDMA48 pDMA46 BamHI fragment in BamHI-digested pEVS122; internal ampG fragment oriVR6K oriTRP4 Emr This study
pDMA74 Internal ltgA fragment (PCR product; primers dma58 and dma59, ES114 template) in pCR-BluntII TOPO; Knr This study
pDMA75 Internal ltgY fragment (PCR product; primers dma60 and dma61, ES114 template) in pCR-BluntII TOPO; Knr This study
pDMA76 Internal ltgD fragment (PCR product; primers dma62 and dma63, ES114 template) in pCR-BluntII TOPO; Knr This study
pDMA77 ampG complementing fragment (PCR product; primers dma52 and dma53, ES114 template) in pCR-BluntII
TOPO; Knr
This study
pDMA89 pDMA74 BglII fragment in BamHI-digested pEVS122; internal ltgA fragment; oriVR6K oriTRP4 Emr This study
pDMA90 pDMA75 BglII fragment in BamHI-digested pEVS122; internal ltgY fragment; oriVR6K oriTRP4 Emr This study
pDMA91 pDMA76 BglII fragment in BamHI-digested pEVS122; internal ltgD fragment; oriVR6K oriTRP4 Emr This study
pDMA96 	1.5-kb fragment downstream of ampG stop (PCR product; primers 55 and dma57, ES114 template) in
SmaI-digested pEVS79; oriVColE1 oriTRP4 Cmr
This study
pDMA100 	1.5-kb fragment upstream of ampG start (PCR product; primers dma54 and dma56, ES114 template) in
HpaI-digested pJLB103; oriVR6K Knr
This study
pDMA104 Internal lysM fragment (PCR product; primers dma76 and dma77, ES114 template) in pCR-BluntII TOPO; Knr This study
pDMA105 pDMA96 SmaI digested fused to SmaI-digested pDMA100; oriVColE1 oriVR6K oriTRP4 Knr Cmr This study
pDMA106 pDMA77 SpeI-XbaI fragment in SpeI-XbaI-digested pEVS79; oriVColE1 oriTRP4 Cmr This study
pDMA108 pDMA104 BglII fragment in BamHI-digested pEVS122; internal lysM fragment; oriVR6K oriTRP4 Emr This study
pDMA109 Internal ltgE fragment (PCR product; primers dma78 and dma79) BamHI digested in BamHI-digested pEVS122;
oriVR6K oriTRP4 Emr
This study
pDMA110 pDMA105 AvrII-SpeI digested and self-ligated; ampG allele; oriVColE1 oriTRP4 Cmr This study
pDMA115 pDMA106 SpeI-XbaI fragment in AvrII-digested pVSV104; V. fischeri ampG in shuttle vector pVSV104;
oriVR6K oriTRP4 oriVpES213 Knr
This study
pDMA176 	1.5-kb fragment upstream of ltgA start (PCR product; primers dma95 and dma99, ES114 template) in
pCR-BluntII TOPO; Knr
This study
pDMA177 ltgA complementing PCR fragment (primers dma97 and dma98, ES114 template) in
pCR-BluntII TOPO
This study
pDMA185 	1.5-kb fragment downstream of ltgA stop (PCR product; primers dma96 and dma100, ES114 template) in pCR-
BluntII TOPO; Knr
This study
pDMA186 pDMA182 XhoI digested and self-ligated; oriVR6K oriTRP4 Cmr This study
pDMA187 pDMA185 SmaI fragment in SmaI-digested pDMA186; ltgA allele; oriVR6K oriVColE1 oriTRP4 Cmr This study
pDMA191 	1.5-kb fragment downstream of ltgD stop (PCR product; primers dma102 and dma106, ES114 template) in
pCR-BluntII TOPO; Knr
This study
pDMA196 pDMA177 SpeI-XhoI fragment in SpeI-XhoI-digested pVSV107; ltgA in shuttle vector pVSV107; oriVR6K
oriTRP4 oriVpES213 Tpr lacZ
This study
pDMA197 	1.5-kb fragment upstream of ltgD start (PCR product; primers dma105 and dma115, ES114 template) in
SmaI-digested pEVS122; oriVR6K oriTRP4 Emr
This study
pDMA198 pDMA191 KpnI-XbaI fragment in KpnI-XbaI-digested pEVS79; oriVColE1 oriTRP4 Cmr This study
pDMA199 pDMA198 SmaI digested fused to SmaI-digested pDMA197; ltgD allele; oriVColE1 oriVR6K oriTRP4 Cmr Emr This study
pEVS79 oriVColE1 oriTRP4 Cmr 65
pEVS104 oriVR6K oriTRP4 Knr RP4-derived conjugative helper plasmid 65
pEVS118 oriVR6K oriTRP4 Cmr 16
pEVS122 oriVR6K oriTRP4 Emr lacZ 16
pJLB103 pVSV104 BamHI digested and self-ligated; oriVR6K Knr lacZ This study
pVSV102 oriVR6K oriTRP4 oriVpES213 Knr gfp 17
pVSV104 oriVR6K oriTRP4 oriVpES213 Knr lacZ 17
pVSV107 oriVR6K oriTRP4 oriVpES213 Tpr lacZ 17
Continued on following page
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Luminescence and motility assays. Motility and luminescence were assessed as
described previously (1). Luminescence of cells cultured in SWTO (4) at 24°C
was determined using a TD 20/20 luminometer (Turner Designs, Sunnyvale,
CA). For motility assays, cultures were grown to mid-log phase (OD595 of 0.5) at
24°C, 5 l of the culture was spotted onto a quadrant of an SWT soft (0.25%)
agar plate, and diameter measurements of the movement away from the point of
inoculation were taken every hour. For each spot, a slope estimate was obtained
from a simple linear regression of diameter versus time to quantify the velocity
of spread, defined as the motility rate.
Squid colonization assays. For infection with individual V. fischeri strains, E.
scolopes juveniles were inoculated within 4 h of hatching as previously described
(58). E. scolopes squid were maintained in Instant Ocean (Aquarium Systems,
Mentor, OH) mixed to 	36 ppt, and cultures for inoculation were grown as
previously described (17). Hatchlings were exposed to inocula for up to 14 h
before being rinsed in V. fischeri-free Instant Ocean. To study infection kinetics,
hatchlings were placed in 5 ml of inoculant in 20-ml glass vials and luminescence
was monitored using an LS6500 scintillation counter (Beckman-Coulter, Fuller-
ton, CA). To determine whether a mutant had a competitive disadvantage in the
symbiosis relative to the wild type, animals were exposed to a 	1:1 mix of the
wild-type and mutant strains for 14 h and then moved to V. fischeri-free Instant
Ocean. Individual squid were homogenized and plated after 48 or 96 h, and 50
colonies were patched onto LBS-Em to determine the ratio of mutant to wild
type. The relative competitive index was determined by dividing the mutant-to-
wild-type ratio in each individual squid by the ratio in the inoculum. Log-
transformed data were used to calculate the average relative competitive index
and to determine statistical significance.
Assessment of how effectively juvenile squid colonized with one strain could be
secondarily infected with another strain was performed as previously described
(32, 73). Newly hatched animals were infected with the wild type or DMA388 as
described above. At 72 h postinfection, approximately 2.5 
 104 CFU/ml of the
secondary inoculant AKD200 (mini-Tn7 Cmr) was added for 14 h. At 120 h after
the initial inoculation began, animals were homogenized and plated on LBS to
determine total CFU and on LBS-Cm to estimate the proportion of symbionts
from the secondary infection. Mini-Tn7 Cmr inserts at a single intergenic att site
in V. fischeri, and this does not affect colonization competitiveness (39), making
AKD200 an appropriate marked strain for this purpose.
Squid morphogenesis assays. Animals were infected with strains as described
above. At the specified times after inoculation, infected and aposymbiotic ani-
mals were stained with both Cell Tracker orange and Tubulin Tracker green
(Invitrogen, Carlsbad, CA) for approximately 1 h. After staining, animals were
anesthetized by adding an equal volume of 0.37 M MgCl2 and dissected to expose
the light organ on the ventral side. Regression of the ciliated epithelial append-
ages was determined by epifluorescence microscopy with a Nikon (Melville, NY)
Eclipse E600 microscope using a 51004 V2 fluorescein isothiocyanate-tetram-
ethyl rhodamine isocyanate dual-label filter set (Chroma Technology Corp.,
Rockingham, VT) and/or a Nikon 96157 tetramethyl rhodamine isocyanate filter
set. The latter filter set was used in conjunction with a Nikon Coolpix 5000
camera to obtain the epifluorescence images shown of animals stained with Cell
Tracker. Regression stage (stages 0 to 4) was scored blindly, as set forth by Doino
and McFall-Ngai (15). The E. scolopes light organ is bilobed, and each of the two
lobes was scored separately, although we never observed an animal with lobes at
different stages of regression. Images taken by scanning electron microscopy
(SEM) are provided to help illustrate the appearance of regression stages, but
animals were not scored for regression by SEM in this study.
RESULTS
Bioinformatic analysis of PG synthesis and recycling in V.
fischeri. Before the 921-Da PG monomer known as TCT (13,
57) or PGCT (56, 62) can be released from gram-negative
bacteria, it must first be generated intracellularly, and this
occurs even in bacteria such as E. coli that do not shed PG
monomers. Based on our understanding of E. coli, this PG
monomer apparently is not generated during de novo PG syn-
thesis but rather is produced during PG remodeling and con-
sumed by recycling pathways (55). To examine whether de
novo PG synthesis or PG recycling might be substantively dif-
ferent in V. fischeri, we examined its genome and found ho-
mologs of the E. coli PG synthesis and recycling pathways (see
Table S1 in the supplemental material). Only minor deviations
from the E. coli PG processing systems were evident. V. fischeri
possesses only one homolog (AmiB) of the four amidases that







dma30 5 GCCAGATCTGTCATTGGTTGGTGGACAGGCTAT 3 This study
dma31 5 CGGAGATCTCCCAGCCGATCAGTTTAGAGTA 3 This study
dma52 5 CTTCATGGCTCAAGGTGGTGGTTT 3 This study
dma53 5 GGCCTCCTAGATTAGGAGGCTTTG 3 This study
dma54 5 GGTTGTGGCAATGGAGTACTCAGTG 3 This study
dma55 5 TTCTGGGTTCCAATCGACACTTGG 3 This study
dma56 5 CCGCCCGGGCATGAAACGCTCCTTGTTATTTGTTC 3 This study
dma57 5 GCCCCCGGGTAAGTTCTTATACGTAACAACTGTGCTAC 3 This study
dma58 5 GGCAGATCTGGGCTGAAGCTGGGAAACTCAGTGATGATT 3 This study
dma59 5 CGGAGATCTTGCACGAATAGCAACACGAATTCGGCG 3 This study
dma60 5 CGGAGATCTCGTCAGCCTGAAAAGTTTACCGTGG 3 This study
dma61 5 CGGAGATCTCCGCACTCTTGGCTTGATTCTCTTT 3 This study
dma62 5 GGCAGATCTCGAATTGGTGAAGAGTATGGCGTTCAAC 3 This study
dma63 5 CGGAGATCTCCTAGCTCTTGCCATTGTGCTAACG 3 This study
dma76 5 GGCAGATCTCCTTAGAATCAACGGTAAGTACGCTAGAGTC 3 This study
dma77 5 CCGAGATCTGCTCAACTTGTTGTTGTGCTTGCTG 3 This study
dma78 5 GCCGGATCCGCAACAACCGCAGCCTTAGATTACATG 3 This study
dma79 5 GCCGGATCCGCAATGGCAAGATCTAACTGCTGCTT 3 This study
dma95 5 GCGTCTTTCAATCATTAGGCTACT 3 This study
dma96 5 CCGCGAAACCTGTTCGA 3 This study
dma97 5 GATTCATCAAGTACAGGTTCTTGGG 3 This study
dma98 5 CGGCCCGGGGGATCCTCAATACTTTAAATTCAGCTCTTTCTCGG 3 This study
dma99 5 CGGCCCGGGCATTGATTTCTTTAACACCTAAACTTTCCAA 3 This study
dma100 5 GCCCCCGGGTGATAAGTTTAAATTCTAATAGCAATTGGTATTAAGC 3 This study
dma102 5 GGCAAGAATATGACCAGCGTCGTTTTG 3 This study
dma105 5 CGGCCCGGGCATATAATTAATTCTCTTCTCTTGCTGCTTTATCT 3 This study
dma106 5 CGCCCCGGGTAACAGAGCAGGGTTCAGATCGCTTC 3 This study
dma115 5 TGGCTTTTTTCTGTGGTCTAAAAAA 3 This study
a Abbreviations: Knr, kanamycin resistance; Strr, streptomycin resistance; Tpr, trimethoprim resistance.
b Underlined sequences indicate restriction enzyme recognition sites added to primers (BglII, A/GATCT; BamHI, G/GATCC; or SmaI, CCC/GGG).
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but it seems reasonable that one such amidase might be suffi-
cient. V. fischeri also lacks a clear homolog of LdcA, an L,D-
carboxypeptidase found in the E. coli PG monomer recycling
pathway (67); however, it does appear to encode distinct pep-
tidases not found in E. coli, including a putative PG-targeting
peptidase (encoded by ORF VF2017). Moreover, all of the
functions downstream of LdcA in the recycling pathway appear
intact. Based on these results, we speculated that V. fischeri’s
net release of PG monomer might parallel either the poor
ampG expression of B. pertussis or the high activity of lytic
transglycosylases of N. gonorrhoeae, and we investigated these
possibilities further.
Analysis of AmpG in V. fischeri. The single AmpG homolog
found in BLAST searches of the V. fischeri genome is encoded
by ORF VF0720, which shares 26% identity and 49% similarity
with E. coli AmpG. The V. fischeri AmpG amino acid sequence
is shorter than that of E. coli at the C terminus by 73 amino
acids; however, N. gonorrhoeae AmpG is similarly shorter than
E. coli AmpG by 77 amino acids, yet it has demonstrated
functionality (18).
Mutation of ampG increases the net release of PG mono-
mers. To test the functionality of V. fischeri AmpG in PG
monomer recycling, we used an HPLC-based method for
PG monomer detection (12, 31) to analyze the amount of PG
monomer accumulated extracellularly during log-phase growth
of DMA350 (ampG::pDMA48) relative to that of the wild
type. We saw an increase in net PG monomer release from
DMA350 (ampG::pDMA48) of approximately 39-fold (data
not shown). Next, we generated an in-frame deletion mutant of
ampG and found that DMA352 (ampG) had more than a
100-fold increase in net PG monomer release (Fig. 1). This
phenotype could be complemented by the introduction of
ampG on a stable plasmid (pDMA115), decreasing the extra-
cellular levels of PG monomer accumulation back to wild-type
levels (Fig. 1). We occasionally saw a decrease in the amount
of net PG monomer release when ampG was added in multi-
copy in trans to ES114; however, this result was not consistent
from experiment to experiment, and this apparent slight effect
is not statistically significant (P  0.05; Fig. 1). These data
suggest that V. fischeri AmpG is functional, and unlike the
situation in B. pertussis, lack of AmpG is probably not respon-
sible for the extracellular accumulation of PG monomers in
cultures of V. fischeri.
Analysis of lytic transglycosylases in V. fischeri. In N. gonor-
rhoeae the activity of lytic transglycosylases is responsible for
the large amounts of PG monomer accumulated in culture
supernatants. Therefore, we examined whether V. fischeri had
homologs to the N. gonorrhoeae lytic transglycosylases, LtgA
and LtgD, which are important for release of PG monomers
during log-phase growth in N. gonorrhoeae (9, 10). Two ho-
mologs to the N. gonorrhoeae LtgA sequence were found in V.
fischeri, and these are encoded by VF0558 and VF1329 (see
Table S1 in the supplemental material). VF0558, now termed
ltgA, is well conserved in sequence and genetic context within
the family Vibrionaceae, and the predicted amino acid se-
quence for V. fischeri LtgA has 24% identity and 43% similarity
to that for N. gonorrhoeae LtgA. VF0558 and N. gonorrhoeae
LtgA were best matches in reciprocal genome searches, lead-
ing to the designation of VF0558 as ltgA. The other LtgA-like
protein, encoded by VF1329, is now designated ltgY to distin-
guish it from ltgA (VF0558) while avoiding the names of genes
such as ltgB or ltgC that encode more-dissimilar proteins in N.
gonorrhoeae. The ltgY gene is related to ltgA but appeared
absent from the other members of the Vibrionaceae family that
we examined. The predicted amino acid sequence of LtgY
shares 34% identity and 55% similarity with that of V. fischeri
LtgA and 24% identity and 42% similarity with that of N.
gonorrhoeae LtgA. Only one homolog to N. gonorrhoeae LtgD
was found in V. fischeri, and this is encoded by VF1702. A
reciprocal search found that in the N. gonorrhoeae FA1090
genome LtgD is likewise the protein most similar to that en-
coded by VF1702. This V. fischeri gene, now termed ltgD, has
a conserved upstream genetic context within the Vibrionaceae
family, although the downstream genetic context is different.
The predicted amino acid sequence of V. fischeri LtgD had
30% identity and 48% similarity to the N. gonorrhoeae LtgD
sequence.
We also searched the ES114 genome for other genes poten-
tially encoding lytic transglycosylases. Two ORFs, VF1939 and
VF1247, were found to encode LysM domains that are impor-
tant in general PG binding and have the potential to be PG
hydrolases (6). These ORFs were named ltgE and lysM, respec-
tively. Based on genome comparisons, VF1247 (ltgE) encodes
a reciprocal best match to both the membrane-bound lytic
murein transglycosylase MltD in E. coli (see Table S1 in the
supplemental material) and LtgE in N. gonorrhoeae. We have
designated VF1247 as ltgE to be consistent with the nomen-
clature in N. gonorrhoeae (10).
Mutations in lytic transglycosylase genes result in reduced
net release of PG monomers. To determine if any of these
putative lytic transglycosylases were responsible for the release
of PG monomers by V. fischeri, we generated plasmid integra-
tion mutants yielding DMA360 (ltgA::pDMA89), DMA361
(ltgY::pDMA90), DMA362 (ltgD::pDMA91), DMA380 (ltgE::
FIG. 1. Mutation in V. fischeri ampG increases net PG monomer
release in log-phase cultures. PG monomer was measured in culture
supernatants of ES114 (wild type) and DMA352 (ampG) along with
both strains containing plasmids pVSV104 (control vector) and
pDMA115 (ampG in pVSV104). To account for experiment-to-exper-
iment variations, within each experiment each strain’s calculated PG
monomer release was expressed as a percentage of ES114 PG mono-
mer release. Values shown are the averages of three different experi-
ments. The dotted line represents ES114 PG monomer release, de-
fined as 100%, which averaged 20.4 nM per OD595. Error bars are
standard errors. Asterisks indicate significant differences (P  0.05)
from ES114 as determined by Student’s t test.
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pDMA109), and DMA385 (lysM::pDMA108). We then assayed
the effects of the mutations on net PG monomer release as de-
scribed above. DMA360 (ltgA::pDMA89) had threefold-less net
PG monomer release than did the wild type (Fig. 2A). Similarly,
DMA361 (ltgY::pDMA90) and DMA362 (ltgD::pDMA91) each
appeared to accumulate fewer PG monomers in culture superna-
tants than did the wild type, but these differences were not sig-
nificant (P 0.05). Finally, both DMA380 (ltgE::pDMA109) and
DMA385 (lysM::pDMA108) appeared unaffected in net PG
monomer release (Fig. 2A).
In N. gonorrhoeae multiple mutations in the lytic transglyco-
sylase genes are necessary to drastically reduce the accumula-
tion of PG monomer in cultures. To determine whether this
might be the case in V. fischeri, we constructed in-frame dele-
tions of ltgA and ltgD, resulting in DMA363 (ltgA) and
DMA368 (ltgD), respectively. These alleles were combined
with the ltgY::pDMA90 allele construct both in pairwise com-
binations and to generate a triple mutant. The ltgA allele
combined with other mutations resulted in significantly less
extracellular accumulation of PG monomer. This was true for
DMA369 (ltgA ltgD), DMA386 (ltgA ltgY::pDMA90), and
DMA388 (ltgA ltgD ltgY::pDMA90), the last of which has
very low (2  1 nM per OD595) levels of PG monomer in
culture supernatants (Fig. 2B).
It is not clear why the ltgA::pDMA89 mutation appears to
have a greater effect on PG monomer release (Fig. 2A) than
does the ltgA allele (Fig. 2B). We cannot rule out the possi-
bility that allelic differences affect PG monomer release—for
example, if a truncated LtgA in the ltgA::pDMA89 mutant
interfered with other lytic transglycosylases; however, this ap-
parent difference between mutants may simply reflect variabil-
ity in this assay, as the ltgA::pDMA89 and ltgA mutants were
not examined together. In this regard, it should be noted that
the amount of PG monomer measured in supernatants from
the wild type was smaller for the experiment in Fig. 2B than it
was for the experiment in Fig. 2A (see figure legend), and the
unusually low value for the wild type in Fig. 2B alone could
explain why PG monomer released by the mutants expressed
as a percentage of the wild-type value would appear higher in
this data set.
Growth, motility, and luminescence of ampG and lytic trans-
glycosylase mutants. Mutations affecting recycling and remod-
eling of PG could affect cell division, growth, motility, and even
metabolism. However, all mutants had wild-type-like growth,
cell morphology, and bioluminescence (data not shown), indi-
cating that these are not generally attenuated strains. Mutants
also had at least 80% to 99% motility relative to that of the
wild type (data not shown), and a previous study found that
these swimming rates are sufficient to confer full symbiotic
competence (1).
Symbiotic competence of DMA352 (ampG) and DMA388
(ltgA ltgD ltgY::pDMA90). One of our goals was to examine
the effect of altered extracellular PG monomer accumulation
on symbiotic colonization. We therefore examined the symbi-
otic competence of the mutants with the greatest deviations in
net PG monomer release; DMA352 (ampG) and DMA388
(ltgA ltgD ltgY::pDMA90). In single-strain infections of
squid, neither DMA352 nor DMA388 showed a difference
from the wild type (data not shown). Competition experiments
have been used previously as a measure of relative symbiotic
proficiency, revealing colonization defects not apparent in sin-
gle-strain inoculations (4, 29, 32, 34, 35, 46, 53, 64, 70, 71, 74,
75). However, there was no apparent competitive defect 48 h
or 96 h postinoculation when either DMA352 (ampG) or
DMA388 (ltgA ltgD ltgY::pDMA90) was coinoculated along
with the wild type (data not shown).
Mutant effects on host light-organ morphogenesis. Because
PG monomers act as a morphogen triggering regression of the
ciliated appendages on the light organ (31), we investigated
whether mutations affecting the net amount of PG monomer
released would alter this morphogenesis. Animals inoculated
with DMA352 (ampG) and examined at 24-h intervals up to
120 h showed ciliated appendage regression similar to that in
animals infected with the wild type. Thus, the 	100-fold in-
crease in net PG monomer release by the ampG mutant in
FIG. 2. Mutations in V. fischeri lytic transglycosylases result in a decrease in net PG monomer release in log-phase cultures. Values are the
averages of three different experiments  standard errors. The dotted line represents ES114 PG monomer release, defined as 100%. Asterisks in
both panels indicate significant differences (P 0.05) from ES114 as determined by Student’s t test. (A) Plasmid-insertion mutants with disruptions
in ltgA, ltgY, ltgD, ltgE, and lysM. The wild type averaged 28 nM per OD595. (B) Comparison of mutants with combinations of in-frame deletion
mutations ltgA and ltgD and a plasmid-insertion mutation in ltgY. The wild type for this set of experiments averaged 14 nM per OD595.
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culture did not appear to correlate with more rapid regression
of the ciliated appendages.
We next examined whether the ampG mutation could trig-
ger morphogenesis in a strain that could not colonize the
light-organ crypts. Nonmotile V. fischeri strains do not enter
the light-organ crypts and do not induce regression (15), al-
though they are able to induce mucus production from the
ciliated fields and can form aggregates outside the pores of the
light organ (53). We therefore tested whether a nonmotile
strain generating large amounts of extracellular PG monomer
might be able to induce regression without colonizing the light-
organ crypt, by constructing a flaJ ampG double mutant. We
then compared morphogenesis in animals inoculated with the
wild type, DM131 (flaJ::aph), or DMA354 (ampG flaJ::aph).
To ensure that the nonmotile flaJ mutants did not infect the
light-organ crypts, each of the three strains used was labeled
with the stable gfp-expressing plasmid pVSV102 (17), and epi-
fluorescence microscopy confirmed that only wild-type cells
could be visualized colonizing the crypts.
At 72 and 96 h postinoculation, wild-type-infected animals
all displayed regression of the ciliated epithelial appendages
(Fig. 3). In contrast, animals infected with DM131 (flaJ::aph)
displayed essentially no regression (a few animals were scored
at stage 1 regression), consistent with previous reports com-
paring the wild type to nonmotile mutants (21, 45). However,
more than half of the animals inoculated with DMA354
(ampG flaJ::aph) showed regression, with some animals pro-
gressing as far as stage 3 (Fig. 3), even though the flaJ mutation
blocked invasion of the light-organ crypts. We considered the
possibility that PG monomer already present in the inoculum
might be inducing regression, as Koropatnick et al. observed
with as little as 10 nM purified PG monomer (31); however,
assuming that net PG monomer release was similar under the
growth conditions used to prepare inocula to the net PG
monomer release in minimal media, then carryover of PG
monomer from the inoculum should have resulted in animals
being exposed to only 	10 pM PG monomer in these experi-
ments. Moreover, similar results were obtained when DMA354
(ampG flaJ::aph) cells were washed in Instant Ocean before
hatchlings were exposed to them. This result suggests that the
regression induced by DMA354 (ampG flaJ::aph) is due to
bacteria aggregating and shedding high levels of PG monomer
in situ, on the light organ.
Our next goal was to see if the small amount of net PG mono-
mer release by the lytic transglycosylase mutant DMA388 (ltgA
ltgD ltgY::pDMA90) would reduce the stimulation of mor-
phogenesis. It did appear that there was less regression of the
ciliated appendages in animals infected with DMA388 (ltgA
ltgD ltgY::pDMA90) than in animals infected with the wild
type; however, using the semiquantitative scoring of regression
stages 0 to 4 defined previously (15), we did not see a consis-
tent and statistically significant difference in these treatments
(data not shown). We also observed what appeared to be more
dense and active fields of cilia on the appendages of DMA388-
FIG. 3. A nonmotile ampG mutant triggers regression of the ciliated
appendages of the light organ. (A) Light-organ ciliated appendages observed
by epifluorescence microscopy (Epi) and SEM to illustrate regression stages.
Each image is approximately 100-fold enlarged and shows one lobe of a
roughly symmetrical bilobed organ. Labels: aa, anterior appendage; pa, pos-
terior appendage; p, one of three closely grouped pores (indicated only in
epifluorescence image); cr, ciliated ridge (indicated only in SEM image).
Epifluorescence images highlight epithelial cells in the appendages stained
with Cell Tracker orange, and SEM images show the fuzzy appearance of the
cilia extending from such epithelial cells. In stage 1 regression, fields of ciliated
cells thin out, notably in the ciliated ridge and anterior appendage, but both
appendages are still present. In stage 2, the posterior appendage is only a nub
and the anterior appendage has shortened. In stage 3, the anterior appendage
is a nub and the posterior appendage is absent. Stage 4 is not pictured and
represents the complete loss of ciliated appendages, as described by Doino
and McFall-Ngai (15). (B and C) Freshly hatched juvenile animals were
inoculated with 	2,500 CFU/ml of either ES114 (wild type), DM131
(flaJ::aph), or DMA354 (ampG flaJ::aph), each of which was labeled with
the gfp-expressing plasmid pVSV102 to confirm that the nonmotile flaJ mu-
tants did not infect the interior light-organ crypts. Animals were stained at
72 h (B) or 96 h (C) postinoculation and scored blindly for regression stage as
illustrated in panel A. The data presented are combined from three experi-
ments scored at 72 h and three scored at 96 h, with similar results among each
set of three experiments. Twenty to 21 animals inoculated with each
strain were scored at 72 h, and 18 to 21 animals inoculated with each
strain were scored at 96 h.
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infected animals, but again we were unable to quantify and
adequately test this supposition. We therefore sought another
way to measure the status of the ciliated appendages. We
surmised that, if some animals retained their infection-promot-
ing ciliated appendages longer, these animals might be more
susceptible to a secondary infection with another bacterial
strain presented well after initial infection. To address this
experimentally, animals were inoculated following hatching
with either the wild-type strain or DMA388 (ltgA ltgD
ltgY::pDMA90), and at 72 h after inoculation with the primary
strain, animals were exposed to a secondary inoculant strain,
AKD200 (mini-Tn7 Cmr). At 120 h post-primary inoculation
(i.e., 48 h post-secondary inoculation), animals were homoge-
nized and plated on LBS to assess total colonization and plated
on LBS-Cm to enumerate bacteria from the secondary infec-
tion. DMA388-infected animals had 10-fold-more bacteria
from the secondary AKD200 infection than did wild-type-in-
fected animals (Fig. 4A and B) and were complemented by the
addition of ltgA on a stable multicopy plasmid (Fig. 4C and D).
Thus, DMA388-infected animals are more prone to secondary
infection, consistent with our perception that the infection-
promoting ciliated appendages were more intact in these
animals.
DISCUSSION
A specific 921-Da component of gram-negative PG referred
to here as PG monomer (and elsewhere as TCT or PGCT) is
usually recycled by bacterial cells, but in instances where PG
monomer is released in significant amounts, it elicits dramatic
effects on host epithelial tissues. When released by the patho-
gen B. pertussis or N. gonorrhoeae, PG monomer causes severe
cytopathology in ciliated human epithelial cells (12, 42). PG
monomer is also released by the mutualistic symbiont V. fisch-
eri, and in its natural host squid, purified PG monomer triggers
regression of ciliated epithelial appendages of the symbiotic
FIG. 4. Animals infected with DMA388 (ltgA ltgD ltgY::pDMA90)
are more susceptible to a secondary infection. Hatchlings were inocu-
lated with either ES114, DMA388 (ltgA ltgD ltgY::pDMA90), DMA388
pVSV107, or DMA388 pDMA196 (ltgA). After 72 h, animals were inocu-
lated with the secondary strain AKD200 (mini-Tn7 Cmr). At 120 h, animals
were homogenized and plated to determine both total CFU and Cmr CFU
corresponding to the secondary colonizers. Values in panels A and B are the
combined averages of six independent experiments, all of which yielded sim-
ilar results (total n  25 for ES114 and n  26 for DMA388). Values in
panels C and D are the combined averages of two independent experiments,
which yielded similar results (total n  9 for ES114, n  10 for DMA388
pVSV107, and n 10 for DMA388 pDMA196). (A and C) Percentages of
total infection comprised by the secondary colonist, AKD200. Each circle
represents a single squid. Open circles represent animals below the limit of
detection for Cmr cells. Horizontal lines show the averages of all animals
within each treatment (panel A, 2% in ES114-infected animals, and 24% in
DMA388-infected animals; panel C, 0.3% in ES114-infected animals, 7.4% in
DMA388 pVSV107-infected animals, and 0.2% in DMA388 pDMA196-
infected animals). (B and D) Averages of both total CFU (open bars) and
CFU from secondary infection by AKD200 (shaded bars). Error bars are
standard errors. Student t tests indicated that secondary infection by AKD200
in DMA388-infected animals was significantly greater (P 0.01) than that in
ES114-infected animals in panel B and that secondary infection by AKD200
in DMA388 pVSV107-infected animals was significantly greater (P  0.05)
than that in ES114- or DMA388 pDMA196-infected animals in panel D.




arch 19, 2014 by W






light organ, reminiscent of the normal developmental program
induced in this symbiosis (31). In this study we generated
mutants of V. fischeri that displayed either increased or de-
creased extracellular accumulation of PG monomer, providing
insight into the basis for PG monomer shedding in this bacte-
rium and the role of PG monomers in this model mutualistic
infection.
We first examined the genetic determinants of PG monomer
release in V. fischeri. In contrast to B. pertussis, where extra-
cellular PG monomer accumulation is thought to be a result of
poor ampG expression (36), V. fischeri AmpG functioned well
in reducing net PG monomer release, as illustrated by the
100-fold increase in PG accumulated in the medium of an
ampG mutant and by the observation that overexpressing
ampG from V. fischeri or E. coli did little to lessen net PG
monomer release (Fig. 1 and data not shown, respectively). V.
fischeri apparently also has a complete recycling pathway (see
Table S1 in the supplemental material), suggesting that V.
fischeri recycles PG monomers as other gram-negative bacteria
do. Apparently, the basis for V. fischeri’s extracellular accumu-
lation of PG monomers is more similar to that of N. gonor-
rhoeae, where the deletion of two lytic transglycosylases results
in the reduced net release of PG monomers (9, 10). In V.
fischeri, mutation of multiple lytic transglycosylases similar to
those in N. gonorrhoeae also reduced net PG monomer release
(Fig. 2B).
The generation of mutants with more or less extracellular
accumulation of PG monomer than that of the wild type en-
abled us to evaluate the importance of this molecule in vivo
during symbiotic infection. When squid were inoculated with
DMA352 (ampG), which accumulates 100-fold-more PG
monomers in culture supernatants than does the wild type (Fig.
1), we did not see a faster progression of light-organ morpho-
genesis (data not shown). This is consistent with the idea that
PG monomer elicits effects on the host as a triggering signal
molecule and that the wild type sheds sufficient PG monomer
to trigger these effects. Interestingly, we did show that a flaJ
ampG double mutant was able to induce regression of the
ciliated light-organ appendages (Fig. 3B and C), unlike the flaJ
mutant and other nonmotile mutants. Nonmotile mutants will
aggregate around the light-organ pores, but they are unable to
colonize the light-organ crypt spaces (21, 53). The inability of
these mutants to stimulate morphogenesis has suggested a
requirement for crypt infection in signal transduction (15),
although it was subsequently shown that purified PG monomer
added to seawater can stimulate morphogenesis (31). The flaJ
ampG double mutant demonstrates that crypt infection is not
necessary for PG-mediated signaling, and this strain should be
a useful tool for separating PG monomer-mediated signaling
from signaling that truly requires infection of the crypts. In the
future, it also will be interesting to compare the effects of this
mutant to the effects of purified PG monomer, to explore
possible PG-independent signaling factors that may be per-
ceived by the host from symbionts still on the light-organ sur-
face.
We also investigated DMA388 (ltgA ltgD ltgY::pDMA90),
which accumulates only low levels of PG monomer in culture
(Fig. 2). We hypothesized that this strain would have reduced
regression of the ciliated light-organ appendages; however, it
still induced regression of the ciliated appendages. A reason
for this could be that another lytic transglycosylase is induced
only in the symbiosis, supplying a mechanism for PG monomer
release that is not evident in culture. By creating gfp-based
transcriptional reporters of each of the lytic transglycosylase
genes listed in Table S1 in the supplemental material, we may
be able to determine if any of the genes are transcriptionally
activated when V. fischeri is within the squid. It is also possible
that a small amount of PG monomer released by this strain is
sufficient to stimulate morphogenesis or that other PG frag-
ments besides the 921-Da fragment could have an effect on
regression. A reduced version of the PG monomer is also
released by V. fischeri (data not shown), and this or other PG
fragments might have important morphogenic activity.
Despite the morphogenesis induced by DMA388 (ltgA
ltgD ltgY::pDMA90), we did perceive a subtle attenuation of
this strain’s ability to stimulate regression of the host’s light-
organ ciliated appendages. A more dramatic or at least more
easily quantifiable effect was evident in the greater susceptibil-
ity of DMA388-infected animals to a secondary V. fischeri
colonist after regression of the infection-promoting ciliated
appendages had begun (Fig. 4). This suggests that even an
apparently small difference in the regression of the ciliated
appendages may have large functional significance with regard
to preventing or allowing further infection by environmental
bacteria. In the future it will be interesting to examine the
effects of DMA388 on specific infection-promoting character-
istics of the ciliated appendages, such as water movement and
mucus secretion (41, 50–53).
The dramatic regression of the infection-promoting ciliated
appendages on the E. scolopes light organ following successful
infection with V. fischeri symbionts can be easily rationalized as
an advantage for the host. This morphogenesis effectively de-
ters further infection, and if these infection-promoting struc-
tures carry any risk of promoting detrimental pathogenic in-
fections, then the risks associated with these structures may
outweigh the advantages once mutualistic symbionts are ob-
tained. Our results illustrate how V. fischeri may also have an
evolutionary impetus for shedding PG monomers. By stimu-
lating morphogenesis, PG monomers help V. fischeri to essen-
tially close the door behind them after initial infection. A
secondary infection with another strain would create competi-
tion within the light organ, potentially causing the initial col-
onizer to lose some of the fitness advantage of colonizing the
light organ. Initiating the regression of the ciliated epithelial
appendages therefore enhances the initial colonizer’s ability to
maintain dominance in the light organ. Further use of second-
ary-infection challenge assays should be valuable in the future,
because mutants that lack the ability to prevent secondary
infections could reveal genes important for stimulating regres-
sion of the ciliated appendages that may not be found using
other screens.
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